Checkmate Pharmaceuticals is a clinical stage company pursuing a novel approach to specifically activating the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells. The company is leveraging its extensive expertise and experience in the field of CpG oligonucleotides (ODN) to evaluate the ability of CMP-001 (a CpG-A ODN) to stimulate an anti-tumor T cell response in combination with chec...
Checkmate Pharmaceuticals is a clinical stage company pursuing a novel approach to specifically activating the innate and adaptive arms of the immune system to recognize and ultimately destroy tumor cells. The company is leveraging its extensive expertise and experience in the field of CpG oligonucleotides (ODN) to evaluate the ability of CMP-001 (a CpG-A ODN) to stimulate an anti-tumor T cell response in combination with checkpoint inhibition to overcome a tumor’s ability to suppress the immune response. CMP-001 is the only CpG-A in clinical development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.